Quality Management
Building a Quality Management System for a medical device company isn't about assembling SOP templates — it's about designing a system that operates correctly under real conditions, supports FDA submission requirements, and sustains compliance after the consultants leave.
Start Your QMS BuildBuilding the Foundation
Medical device startups building their first QMS face a strategic decision early: should they start from off-the-shelf SOP templates, implement an electronic QMS (eQMS) platform, or build from scratch? Each approach has genuine trade-offs, and the right answer depends on the company's size, device class, development stage, and long-term quality objectives.
Template-based QMS builds are fast and low-cost, but they consistently produce systems where the procedures describe a generic process rather than the company's actual operations. This creates a specific and recurring audit risk: auditors look for evidence that the QMS is actually implemented, and a procedure that doesn't match operational reality is a finding regardless of how well-written it is.
eQMS platforms (Veeva Vault QMS, MasterControl, Greenlight Guru, and others) provide document control infrastructure, training management, CAPA workflows, and audit trails that a paper system can't match at scale. For companies planning to grow beyond 20–30 employees, or companies pursuing ISO 13485 certification where audit trail requirements are stringent, an eQMS investment at the outset is usually the right call. We guide eQMS selection and implementation alongside QMS development — not as a separate project.
21 CFR Part 820 and ISO 13485 both require documented procedures for quality system activities, but they do not require equal depth across all areas. A risk-based approach to SOP development allocates documentation effort where it matters most — design controls, CAPA, nonconforming product, production and process controls — while keeping lower-risk administrative procedures appropriately concise.
The most common mistake in first-generation QMS builds is over-engineering administrative procedures and under-engineering the technical ones. A 30-page SOP for document control when a 5-page procedure would suffice, combined with a one-page CAPA procedure that doesn't explain how to conduct root cause analysis, produces a QMS that will generate findings on the things that matter and waste effort on the things that don't.
We write procedures at the right level of specificity based on regulatory risk, inspection history in the device category, and operational complexity. Every procedure is written to describe what the organization actually does — not what a generic template says a medical device company should do.
For companies developing Class II or Class III devices, design controls (21 CFR 820.30, ISO 13485 Clause 7.3) are the most complex and highest-stakes QMS element. The design control system governs the entire product development process from design planning through design transfer to manufacturing — and the design history file (DHF) must document that traceability throughout.
The design history file is inspected in essentially every FDA device inspection and ISO 13485 audit. A DHF that is incomplete, inconsistently structured, or that doesn't demonstrate traceability from user needs through design inputs, design outputs, verification, and validation is a finding. We design DHF architecture that is auditable, scalable as the product evolves, and aligned to the specific regulatory requirements for the device's classification and intended submission pathway.
A QMS built without consideration of the submission requirements it must support creates a second workstream — retro-fitting regulatory documentation after the fact — that adds cost and time to every submission program. The DHF needs to be built to support a 510(k) or PMA. The risk management file needs to align with ISO 14971 in a format FDA reviewers can navigate. Software documentation (IEC 62304 compliance artifacts) needs to be structured for submission. We integrate these requirements into QMS design from the outset, so the system produces submission-ready documentation as a byproduct of normal development operations.
Get Started
A QMS that only works on paper is a liability, not an asset. We build systems designed for the real conditions of FDA inspection and ISO audit — not the idealized conditions of a template library.